Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2000American Journal of HematologyOpen Access

Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR

View Full Paper
Ask AI
Bookmark
Share

Authors

TST SugimotoNational Blood Transfusion ServiceHDHiranmoy DasTexas Tech UniversitySIShion ImotoYamaguchi University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sugimoto et al. (2000) studied this question.

synapsesocial.com/papers/6a110e376da82ae745f346d9https://doi.org/10.1002/(sici)1096-8652(200006)64:2<101::aid-ajh5>3.0.co;2-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Disappearance of AML1 ‐MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long‐term remission1995 · 60 citations
  2. 2Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.1996 · 103 citations
  3. 3Thymic stem cells in mouse bone marrow1994 · 103 citations
  4. 4Alternative splicing and genomic structure of the<i>AML1</i>gene involved in acute myeloid leukemia1995 · 272 citations
  5. 5Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation1996 · 191 citations